+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fenofibrate"

From
Dyslipidemia Market Report 2025 - Product Thumbnail Image

Dyslipidemia Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Fibrate Drugs Market Report 2025 - Product Thumbnail Image

Fibrate Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Dyslipidemia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Dyslipidemia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Fenofibrate is a lipid-lowering medication used to treat high cholesterol and triglyceride levels in people with cardiovascular disease. It is a fibrate drug, which works by increasing the breakdown of triglycerides in the liver and reducing the production of very low-density lipoprotein (VLDL) cholesterol. Fenofibrate is also used to reduce the risk of stroke, heart attack, and other heart complications in people with high cholesterol and triglyceride levels. Fenofibrate is available in both generic and brand-name formulations, and is sold in tablet, capsule, and liquid forms. It is typically taken once or twice daily, with or without food. Common side effects of fenofibrate include nausea, stomach pain, and diarrhea. Some companies that produce fenofibrate include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more